Shineco, Inc. is a holding company incorporated in Delaware. As a holding company with no material operations of our own, we conduct our operations through our subsidiaries and in the two years ended June 30, 2023 and 2024, through the VIEs and subsidiaries. Our shares of common stock currently listed on the Nasdaq Capital Markets are shares of our Delaware holding company. The Chinese regulatory authorities could disallow our structure, which could result in a material change in our operations and the value of our securities could decline or become worthless. On December 30, 2022, Shineco Life Science Group Hong Kong Co., Limited (“Shineco Life”), a company established under the laws of Hong Kong and a wholly owned subsidiary of the Company, closed the acquisition of 51% of the issued equity interests of Changzhou Biowin Pharmaceutical Co., Ltd.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 4.8M | - | - | - | - | 13M |
| Net Income | -39M | -22M | -13M | -27M | -31M | 3.2M |
| EPS | $-4,667.00 | $-5,076.00 | $-8,604.00 | $-34,320.00 | $-85,680.00 | $-27,000.00 |
| Free Cash Flow | 0 | -4.2M | -5.4M | -5.7M | -15M | -4.7M |
| ROIC | -27.8% | -64.3% | -41.0% | -10.2% | -70.3% | 5.0% |
| Gross Margin | 8.4% | - | - | - | - | 24.3% |
| Debt/Equity | 0.63 | 1.06 | 0.16 | 0.86 | 0.13 | 0.04 |
| Dividends/Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | - |
| Operating Income | -10M | -17M | -8.8M | -6.2M | -21M | 1.6M |
| Operating Margin | -216.8% | - | - | - | - | 12.1% |
| ROE | -214.2% | -76.7% | -41.0% | -80.2% | -70.3% | 4.9% |
| Shares Outstanding | 0M | 0M | 0M | 0M | 0M | 0M |
SHINECO, INC. passes 0 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 24.3%.
SHINECO, INC. (SISI) has a 5-year average return on invested capital (ROIC) of -36.1%. This is below average and may indicate limited pricing power.
SHINECO, INC. (SISI) has a market capitalization of $128K. It is classified as a small-cap stock.
SHINECO, INC. (SISI) does not currently pay a regular dividend.
SHINECO, INC. (SISI) operates in the Agricultural Production-Crops industry, within the Consumer Defensive sector.
SHINECO, INC. (SISI) generated $-4 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
SHINECO, INC. (SISI) has a debt-to-equity ratio of 1.06. This indicates moderate leverage.
SHINECO, INC. (SISI) reported earnings per share (EPS) of $-5076.00 in its most recent fiscal year.
SHINECO, INC. (SISI) has a return on equity (ROE) of -76.7%. A negative ROE may indicate losses or negative equity.
SHINECO, INC. (SISI) has a 5-year average gross margin of 24.3%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 10 years of financial data for SHINECO, INC. (SISI), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
SHINECO, INC. (SISI) has a book value per share of $922.63, based on its most recent annual SEC filing.